That's pretty much all I wanted to cover in regards to the second reading of this bill. Obviously, a comprehensive process undertaken, which I think has added value in regards to where we are. I think, obviously, in terms of the ability now for this to be implemented to ensure that everyone who requires this will have the ability to have access to this medicine—as a result of this, they now will be in that position. So I'd like to commend this bill to the House.